Renal Solutions' Allient haemodialysis:
This article was originally published in Clinica
Renal Solutions has received US FDA 510(k) clearance to sell an improved version of its Allient sorbent haemodialysis system for chronic and acute haemodialysis applications. The product, which includes the firm's Sorb and Hisorb series of cartridges, incorporates advanced haemocompatible materials in its Pulsar blood pump component, said the Warrendale, Pennsylvania company. Comprising what the firm describes as a unique, pressure-limited, two-chamber design, the Pulsar pump represents "the first significant step forward in dialysis blood pump design in several decades", Renal Solutions claimed. The firm added that its Allient product opened new treatment options, by virtue of its ability to provide short, standard or extended duration haemodialysis therapy using just 1 and 0.5 gallons of ordinary drinking water.
You may also be interested in...
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.